The triple-negative breast carcinoma (TNBC), accounting for up to 20% of breast carcinomas, is the aggressive molecular subtype of breast cancer, characterized by the absence of ERα, progesterone receptor (PgR), and HER2. Here, ESR1 is linked to breast carcinoma.